RenovoRx (RNXT) Institutional Ownership $1.32 -0.05 (-3.31%) As of 01:31 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for RenovoRx (NASDAQ:RNXT)CurrentInstitutional OwnershipPercentage3.10%Number ofInstitutional Buyers(last 12 months)11TotalInstitutional Inflows(last 12 months)$7.48MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$152.15K Get RNXT Insider Trade Alerts Want to know when executives and insiders are buying or selling RenovoRx stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data RNXT Institutional Buying and Selling by Quarter RenovoRx Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2025 AWM Investment Company Inc.2,285,000$2.26M0.3%N/A6.251% 5/16/2025 Alyeska Investment Group L.P.688,577$682K0.0%N/A1.884% 5/16/2025 ADAR1 Capital Management LLC479,883$475K0.1%+143.3%1.313% 5/15/2025 Corsair Capital Management L.P.187,700$186K0.0%N/A0.514% 5/14/2025 Stonepine Capital Management LLC278,188$275K0.3%N/A0.761% 5/13/2025 HighTower Advisors LLC40,000$40K0.0%N/A0.109% 5/9/2025 Chicago Partners Investment Group LLC92,356$97K0.0%N/A0.253% 5/6/2025 AIGH Capital Management LLC3,467,275$3.43M1.4%N/A9.486% 2/17/2025 Citadel Advisors LLC37,757$49K0.0%N/A0.157% 2/13/2025 Renaissance Technologies LLC64,900$84K0.0%N/A0.270% Get the Latest News and Ratings for RNXT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for RenovoRx and its competitors with MarketBeat's FREE daily newsletter. 2/13/2025 ADAR1 Capital Management LLC197,250$254K0.1%-37.4%0.822% 11/16/2024 Geode Capital Management LLC232,937$247K0.0%+61.9%0.971% 2/9/2024 Nixon Peabody Trust Co.97,165$223K0.0%N/A0.909% 7/10/2023 Level Four Advisory Services LLC15,000$34K0.0%+50.0%0.148% 6/5/2023 Level Four Advisory Services LLC10,000$35K0.0%N/A0.099% 1/19/2023 Affinity Capital Advisors LLC15,259$36K0.0%+35.6%0.168% 11/10/2022Cohen Lawrence B54,121$159K0.1%-44.3%0.597% 8/11/2022Cohen Lawrence B97,165$192K0.1%+79.5%1.072% 8/2/2022Bank of The West975,000$1.93M0.2%N/A10.750% 5/13/2022Cohen Lawrence B54,121$159K0.1%N/A0.599% 2/3/2022 Cambridge Investment Research Advisors Inc.14,400$70K0.0%-64.7%0.162% 11/16/2021 Schonfeld Strategic Advisors LLC20,569$125K0.0%N/A0.245% 11/16/2021 Two Sigma Securities LLC17,944$108K0.0%N/A0.214% 11/12/2021 Board of Trustees of The Leland Stanford Junior University60,863$368K0.0%N/A0.726% 11/2/2021 Cambridge Investment Research Advisors Inc.40,850$247K0.0%N/A0.487% (Data available from 1/1/2016 forward) RNXT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RNXT shares? During the previous two years, 13 institutional investors and hedge funds held shares of RenovoRx. The most heavily invested institutionals were AIGH Capital Management LLC ($3.43M), AWM Investment Company Inc. ($2.26M), Alyeska Investment Group L.P. ($682K), ADAR1 Capital Management LLC ($475K), Stonepine Capital Management LLC ($275K), Geode Capital Management LLC ($247K), and Nixon Peabody Trust Co. ($223K).Learn more on RNXT's institutional investors. What percentage of RenovoRx stock is owned by institutional investors? 3.10% of RenovoRx stock is owned by institutional investors. Learn more on RNXT's institutional investor holdings. Which institutional investors have been buying RenovoRx stock? Of the 13 institutional investors that purchased RenovoRx stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: AIGH Capital Management LLC ($3.47M), AWM Investment Company Inc. ($2.29M), Alyeska Investment Group L.P. ($688.58K), ADAR1 Capital Management LLC ($282.63K), Stonepine Capital Management LLC ($278.19K), Corsair Capital Management L.P. ($187.70K), and Nixon Peabody Trust Co. ($97.17K). How much institutional buying is happening at RenovoRx? Institutional investors have bought a total of 7,615,569 shares in the last 24 months. This purchase volume represents approximately $7.71M in transactions. Which RenovoRx major shareholders have been selling company stock? The following institutional investors have sold RenovoRx stock in the last 24 months: ADAR1 Capital Management LLC ($117.94K). How much institutional selling is happening at RenovoRx? Institutional investors have sold a total of 117,942 shares in the last 24 months. This volume of shares sold represents approximately $152.15K in transactions. Related Companies IPHA Major Shareholders SCPH Major Shareholders DRUG Major Shareholders SOPH Major Shareholders ACTU Major Shareholders BTMD Major Shareholders INBX Major Shareholders KOD Major Shareholders ESPR Major Shareholders TIL Major Shareholders This page (NASDAQ:RNXT) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RenovoRx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RenovoRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
